Receptors, Interleukin-13
"Receptors, Interleukin-13" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell surface receptors for INTERLEUKIN-13. Included under this heading are the INTERLEUKIN-13 RECEPTOR ALPHA2 which is a monomeric receptor and the INTERLEUKIN-4 RECEPTOR TYPE II which has specificity for both INTERLEUKIN-4 and INTERLEUKIN-13.
MeSH Number(s)
D12.776.543.750.705.852.420.600
Concept/Terms
Receptors, Interleukin-13- Receptors, Interleukin-13
- Receptors, Interleukin 13
- IL-13 Receptors
- IL 13 Receptors
- Receptors, IL-13
- Interleukin-13 Receptors
- Interleukin 13 Receptors
- Receptor, Interleukin-13
- Receptor, Interleukin 13
- IL-13 Receptor
- IL 13 Receptor
- Receptor, IL-13
- Interleukin-13 Receptor
- Interleukin 13 Receptor
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-13".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-13".
This graph shows the total number of publications written about "Receptors, Interleukin-13" by people in Harvard Catalyst Profiles by year, and whether "Receptors, Interleukin-13" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 3 | 3 |
| 2003 | 0 | 3 | 3 |
| 2005 | 0 | 1 | 1 |
| 2007 | 1 | 1 | 2 |
| 2012 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
Below are the most recent publications written about "Receptors, Interleukin-13" by people in Profiles.
-
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence. Genes (Basel). 2022 12 15; 13(12).
-
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma. Ann Allergy Asthma Immunol. 2021 05; 126(5):584-592.e1.
-
N-Glycosylation Regulates Chitinase 3-like-1 and IL-13 Ligand Binding to IL-13 Receptor a2. Am J Respir Cell Mol Biol. 2020 09; 63(3):386-395.
-
Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets. Am J Pathol. 2012 Mar; 180(3):1080-1094.
-
Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expression. J Rheumatol. 2012 Jan; 39(1):112-8.
-
IL-13 induces the expression of the alternative activation marker Ym1 in a subset of testicular macrophages. J Reprod Immunol. 2008 Jul; 78(2):140-8.
-
Increased hyperoxia-induced mortality and acute lung injury in IL-13 null mice. J Immunol. 2007 Apr 15; 178(8):4993-5000.
-
Regulation of IL-13 receptors in human keratinocytes. J Invest Dermatol. 2007 May; 127(5):1271-4.
-
IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome. J Immunol. 2007 Jan 01; 178(1):511-9.
-
Identification of interleukin-13 receptor alpha2 peptide analogues capable of inducing improved antiglioma CTL responses. Cancer Res. 2006 Jun 01; 66(11):5883-91.